scispace - formally typeset
V

Vincent Truong

Researcher at University of Minnesota

Publications -  13
Citations -  375

Vincent Truong is an academic researcher from University of Minnesota. The author has contributed to research in topics: Induced pluripotent stem cell & Stem cell. The author has an hindex of 6, co-authored 10 publications receiving 216 citations.

Papers
More filters
Journal ArticleDOI

3D Printed Stem-Cell Derived Neural Progenitors Generate Spinal Cord Scaffolds.

TL;DR: A bioengineered spinal cord is fabricated via extrusion-based multi-material 3D bioprinting, in which clusters of induced pluripotent stem cell (iPSC)-derived spinal neuronal progenitor cells (sNPCs) and oligodendrocyte progenitors cells (OPCs) are placed in precise positions within 3D printed biocompatible scaffolds during assembly.
DatasetDOI

Supporting data for 3D Printed Stem-Cell Derived Neural Progenitors Generate Spinal Cord Scaffolds

TL;DR: Successful bioprinting of OPCs in combination with sNPCs demonstrates a multicellular neural tissue engineering approach, where the ability to direct the patterning and combination of transplanted neuronal and glial cells can be beneficial in rebuilding functional axonal connections across areas of central nervous system tissue damage.
Journal ArticleDOI

Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration

TL;DR: This successful validation of a standardized, iPSC derivation and RPE differentiation process demonstrates a practical approach for applications requiring the cost-effective generation of RPE from multiple individuals such as drug testing, population studies or for therapies requiring patient-specific RPE derivations.
Journal ArticleDOI

Automating Human Induced Pluripotent Stem Cell Culture and Differentiation of iPSC-Derived Retinal Pigment Epithelium for Personalized Drug Testing

TL;DR: This work demonstrates scalable, reproducible culture and differentiation of hiPSC lines from individuals on the TECAN Fluent platform and illustrates the potential for end-to-end automation ofhiPSC-based personalized drug testing.